News
Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.
Iowa has reported seven cases of measles in 2025, making now the time to check your vaccination status or get the MMR vaccine ...
Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early ...
This study provides valuable findings regarding potential correlates of protection against the African swine fever virus. The evidence supporting the claims is solid, although analysis using a higher ...
New analysis warns that suboptimal clinical trial designs and overreliance on surrogate markers may allow less effective flu ...
Researchers identified key genes in Streptomyces cinnamonensis to enhance monensin production, a widely used antibiotic. By ...
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...
Super Agers author Eric Topol unpacks the rise of biological age tests—from organ clocks to immune system clocks—and how they might revolutionize early diagnosis of disease ...
3d
News-Medical.Net on MSNNasal antibody spray shields mice from pollen-triggered allergies and asthmaIntranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...
2d
News-Medical.Net on MSNOptogenetic platform enables precise discovery of anti-aging therapeuticsA landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...
A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences. The Cell paper demonstrates the platform’s ...
A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results